Eze/Simva Switch Study in Diabetics (0653A-807)

NCT00541697 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

648

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: MK0653A, ezetimibe (+) simvastatin / Duration of Treatment: 6 Weeks
DRUG: Comparator: atorvastatin / Duration of Treatment: 6 Weeks

Sponsor

Organon and Co